Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro C Silberman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
JCO Oncology Practice|July 16, 2025
Trends of Authors' Conflicts of Interest in Clinical Trials Published in the <i>Journal of Clinical Oncology</i>: A Large Language Model-Assisted Longitudinal StudyJiasheng Wang, Pedro C Silberman, Sayan Mullick Chowdhury, et al.
Science Advances|January 22, 2025
Microenvironment actuated CAR T cells improve solid tumor efficacy without toxicityKristen C Vogt, Pedro C Silberman, Qianqian Lin, et al.
EMBO Molecular Medicine|April 14, 2026
Targeted cellular micropharmacies deliver therapeutic agents to the brainManish Malviya, Subha Baniya, Eitan Wong, et al.
Cancers|August 9, 2020
Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug DeliveryThomas J Gardner, Christopher M Bourne, Megan M Dacek, et al.
Cell|June 16, 2015
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell HomeostasisJuan R Cubillos-Ruiz, Pedro C Silberman, Melanie R Rutkowski, et al.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
JCO Oncology Practice|July 16, 2025
Trends of Authors' Conflicts of Interest in Clinical Trials Published in the <i>Journal of Clinical Oncology</i>: A Large Language Model-Assisted Longitudinal StudyJiasheng Wang, Pedro C Silberman, Sayan Mullick Chowdhury, et al.
Science Advances|January 22, 2025
Microenvironment actuated CAR T cells improve solid tumor efficacy without toxicityKristen C Vogt, Pedro C Silberman, Qianqian Lin, et al.
EMBO Molecular Medicine|April 14, 2026
Targeted cellular micropharmacies deliver therapeutic agents to the brainManish Malviya, Subha Baniya, Eitan Wong, et al.
Cancers|August 9, 2020
Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug DeliveryThomas J Gardner, Christopher M Bourne, Megan M Dacek, et al.
Cell|June 16, 2015
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell HomeostasisJuan R Cubillos-Ruiz, Pedro C Silberman, Melanie R Rutkowski, et al.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Pageof 1